As of 2024-12-12, the Intrinsic Value of Constellation Pharmaceuticals Inc (CNST) is
-0.00 USD. This CNST valuation is based on the model Peter Lynch Fair Value.
With the current market price of 33.99 USD, the upside of Constellation Pharmaceuticals Inc is
-100.01%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.00 USD
Intrinsic Value
CNST Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-0.00 - -0.00 |
-0.00 |
-100.01% |
| P/E |
(63.50) - (59.26) |
(67.82) |
-299.5% |
| DDM - Stable |
(62.85) - 891.90 |
414.52 |
1119.5% |
| DDM - Multi |
(54.82) - 601.99 |
(120.28) |
-453.9% |
CNST Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
1,628.62 |
| Beta |
1.01 |
| Outstanding shares (mil) |
47.91 |
| Enterprise Value (mil) |
1,514.62 |
| Market risk premium |
4.24% |
| Cost of Equity |
5.49% |
| Cost of Debt |
5.00% |
| WACC |
4.57% |